BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 14504178)

  • 1. Vascular remodeling induced by naturally occurring unsaturated lysophosphatidic acid in vivo.
    Yoshida K; Nishida W; Hayashi K; Ohkawa Y; Ogawa A; Aoki J; Arai H; Sobue K
    Circulation; 2003 Oct; 108(14):1746-52. PubMed ID: 14504178
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epiregulin as a major autocrine/paracrine factor released from ERK- and p38MAPK-activated vascular smooth muscle cells.
    Takahashi M; Hayashi K; Yoshida K; Ohkawa Y; Komurasaki T; Kitabatake A; Ogawa A; Nishida W; Yano M; Monden M; Sobue K
    Circulation; 2003 Nov; 108(20):2524-9. PubMed ID: 14581411
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of vascular smooth muscle cell proliferation and neointimal formation in injured arteries by a novel, oral mitogen-activated protein kinase/extracellular signal-regulated kinase inhibitor.
    Gennaro G; Ménard C; Michaud SE; Deblois D; Rivard A
    Circulation; 2004 Nov; 110(21):3367-71. PubMed ID: 15520324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Inhibition of intimal thickening in the rat carotid artery injury model by a nontoxic Ras inhibitor.
    George J; Sack J; Barshack I; Keren P; Goldberg I; Haklai R; Elad-Sfadia G; Kloog Y; Keren G
    Arterioscler Thromb Vasc Biol; 2004 Feb; 24(2):363-8. PubMed ID: 14670932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phenotypic modulation of vascular smooth muscle cells induced by unsaturated lysophosphatidic acids.
    Hayashi K; Takahashi M; Nishida W; Yoshida K; Ohkawa Y; Kitabatake A; Aoki J; Arai H; Sobue K
    Circ Res; 2001 Aug; 89(3):251-8. PubMed ID: 11485975
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Therapeutic effect of magnesium lithospermate B on neointimal formation after balloon-induced vascular injury.
    Hur KY; Seo HJ; Kang ES; Kim SH; Song S; Kim EH; Lim S; Choi C; Heo JH; Hwang KC; Ahn CW; Cha BS; Jung M; Lee HC
    Eur J Pharmacol; 2008 May; 586(1-3):226-33. PubMed ID: 18387604
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Xenogenic smooth muscle cell immunization reduces neointimal formation in balloon-injured rabbit carotid arteries.
    Shinohara M; Kawashima S; Yamashita T; Takaya T; Toh R; Ishida T; Ueyama T; Inoue N; Hirata K; Yokoyama M
    Cardiovasc Res; 2005 Nov; 68(2):249-58. PubMed ID: 16039635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rho GTPase, Rac1, regulates Skp2 levels, vascular smooth muscle cell proliferation, and intima formation in vitro and in vivo.
    Bond M; Wu YJ; Sala-Newby GB; Newby AC
    Cardiovasc Res; 2008 Nov; 80(2):290-8. PubMed ID: 18599477
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fluvastatin prevents vascular hyperplasia by inhibiting phenotype modulation and proliferation through extracellular signal-regulated kinase 1 and 2 and p38 mitogen-activated protein kinase inactivation in organ-cultured artery.
    Sakamoto K; Murata T; Chuma H; Hori M; Ozaki H
    Arterioscler Thromb Vasc Biol; 2005 Feb; 25(2):327-33. PubMed ID: 15591221
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sphingosine-1-phosphate induces COX-2 expression via PI3K/Akt and p42/p44 MAPK pathways in rat vascular smooth muscle cells.
    Hsieh HL; Wu CB; Sun CC; Liao CH; Lau YT; Yang CM
    J Cell Physiol; 2006 Jun; 207(3):757-66. PubMed ID: 16508949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. alpha8beta1 Integrin expression in the rat carotid artery: involvement in smooth muscle cell migration and neointima formation.
    Zargham R; Thibault G
    Cardiovasc Res; 2005 Mar; 65(4):813-22. PubMed ID: 15721861
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lysophosphatidic acid induces neointima formation through PPARgamma activation.
    Zhang C; Baker DL; Yasuda S; Makarova N; Balazs L; Johnson LR; Marathe GK; McIntyre TM; Xu Y; Prestwich GD; Byun HS; Bittman R; Tigyi G
    J Exp Med; 2004 Mar; 199(6):763-74. PubMed ID: 15007093
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of an inhibitory effect of pioglitazone on balloon-injured vascular smooth muscle cell growth.
    Igarashi M; Hirata A; Yamaguchi H; Tsuchiya H; Ohnuma H; Tominaga M; Daimon M; Kato T
    Metabolism; 2001 Aug; 50(8):955-62. PubMed ID: 11474485
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids.
    Tokumura A; Sinomiya J; Kishimoto S; Tanaka T; Kogure K; Sugiura T; Satouchi K; Waku K; Fukuzawa K
    Biochem J; 2002 Aug; 365(Pt 3):617-28. PubMed ID: 11982483
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional down-regulation of thromboxane A(2) receptor expression via activation of MAPK ERK1/2, p38/NF-kappaB pathways.
    Zhang W; Zhang Y; Edvinsson L; Xu CB
    J Vasc Res; 2009; 46(2):162-74. PubMed ID: 18769070
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional coupling expression of COX-2 and cPLA2 induced by ATP in rat vascular smooth muscle cells: role of ERK1/2, p38 MAPK, and NF-kappaB.
    Lin CC; Lin WN; Wang WJ; Sun CC; Tung WH; Wang HH; Yang CM
    Cardiovasc Res; 2009 Jun; 82(3):522-31. PubMed ID: 19233864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PDTC, metal chelating compound, induces G1 phase cell cycle arrest in vascular smooth muscle cells through inducing p21Cip1 expression: involvement of p38 mitogen activated protein kinase.
    Moon SK; Jung SY; Choi YH; Lee YC; Patterson C; Kim CH
    J Cell Physiol; 2004 Feb; 198(2):310-23. PubMed ID: 14603533
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Lysophosphatidic acid-induced vascular neointimal formation in mouse carotid arteries is mediated by the matricellular protein CCN1/Cyr61.
    Hao F; Zhang F; Wu DD; An D; Shi J; Li G; Xu X; Cui MZ
    Am J Physiol Cell Physiol; 2016 Dec; 311(6):C975-C984. PubMed ID: 27760754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Critical role of Mst1 in vascular remodeling after injury.
    Ono H; Ichiki T; Ohtsubo H; Fukuyama K; Imayama I; Hashiguchi Y; Sadoshima J; Sunagawa K
    Arterioscler Thromb Vasc Biol; 2005 Sep; 25(9):1871-6. PubMed ID: 15961701
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myocyte enhancer factor 2 mediates vascular inflammation via the p38-dependent pathway.
    Suzuki E; Satonaka H; Nishimatsu H; Oba S; Takeda R; Omata M; Fujita T; Nagai R; Hirata Y
    Circ Res; 2004 Jul; 95(1):42-9. PubMed ID: 15178640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.